Effects of E-Cigarette Flavors on Adult E-Cigarette Users With Opioid Use Disorder
Part of paid clinical trials in Greenville, South Carolina.
- Sponsor
- Prisma Health-Upstate
- Study ID
- NCT07594717
- Status
- Recruiting
Conditions
- Nicotine Use Disoder
- Opioid Use Disorder
Eligibility Criteria
- Sex
- ALL
- Age
- 21 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Sweet-cooling — DRUGSweet-cooling EC flavor
- Sweet non-cooling EC flavor — DRUGSweet non-cooling flavor
- Tobacco flavor EC — DRUGTobacco flavor EC
Study Details
This study examines the effects of e-cigarette (EC) flavors among adults with opioid use disorder (OUD) receiving buprenorphine treatment who currently use e-cigarettes. Participants will smell and rate 11 EC flavors based on appeal, sensory characteristics, and likelihood of future use. Researchers will examine how different flavor profiles influence the appeal and reinforcing effects of ECs in this population. The goal is to identify EC flavors that may enhance the acceptability of ECs as a potential harm-reduction strategy among adults with OUD receiving buprenorphine treatment.
Key Dates
- Start date
- Nov 12, 2025
- Status verified
- May 2026
- Primary completion
- May 31, 2026
- Completion
- May 31, 2026
Study Design
- Enrollment
- 70 participants (estimated)
Primary Outcome Measure
Perceived Sweetness [ Time Frame: Baseline session ]
Central Contacts
- Irene Pericot-Valverde, PhD18549998005
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Prisma Health Recovery Clinic-Greenville | Greenville | South Carolina | 29605 |
Find similar trials in Greenville, SC
By research site
Related Studies
- Development of an mHealth Behavioral Sleep Medicine Intervention for Use During Medication Assisted Treatment for MOUDRecruiting · Medical University of South Carolina · Charleston, South Carolina
- Trauma Screening/Referral and Interpersonal Violence Prevention for Women with Substance Use DisordersRecruiting · Clemson University · Greenville, South Carolina
- Integrated Treatment for Opioid Use Disorder and PTSDRecruiting · Medical University of South Carolina · Charleston, South Carolina
- Evaluation of Tirzepatide as an Adjunct to Buprenorphine for the Treatment of Opioid Use DisorderPHASE2 · Recruiting · T. John Winhusen, PhD · Jacksonville, Florida